Constellation Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $1.6M | Buy |
4,450
+175
| +4% | +$63.1K | 0.29% | 72 |
|
|
2015
Q4 | $2.32M | Buy |
4,275
+75
| +2% | +$40.7K | 0.43% | 54 |
|
|
2015
Q3 | $1.95M | Buy |
4,200
+25
| +0.6% | +$11.6K | 0.4% | 54 |
|
|
2015
Q2 | $2.13M | Buy |
4,175
+125
| +3% | +$63.8K | 0.41% | 57 |
|
|
2015
Q1 | $1.83M | Buy |
4,050
+125
| +3% | +$56.4K | 0.35% | 65 |
|
|
2014
Q4 | $1.61M | Buy |
3,925
+100
| +3% | +$41K | 0.33% | 68 |
|
|
2014
Q3 | $1.38M | Sell |
3,825
-100
| -3% | -$36.1K | 0.31% | 74 |
|
|
2014
Q2 | $1.11M | Buy |
3,925
+50
| +1% | +$14.1K | 0.26% | 94 |
|
|
2014
Q1 | $1.16M | Buy |
3,875
+175
| +5% | +$52.6K | 0.28% | 77 |
|
|
2013
Q4 | $1.02M | Buy |
3,700
+300
| +9% | +$82.5K | 0.26% | 86 |
|
|
2013
Q3 | $1.06M | Buy |
3,400
+250
| +8% | +$78.2K | 0.33% | 73 |
|
|
2013
Q2 | $708K | Buy |
+3,150
| New | +$708K | 0.25% | 91 |
|